Year ended 31 March 2025 | Year ended 31 March 2024 | ||||||
Revenue | Capital | Total | Revenue | Capital | Total | ||
Notes | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | |
(Losses)/gains on Investments | 8 | ( | ( | ||||
Interest Income | |||||||
Expenses | 2 | ( | ( | ( | ( | ( | ( |
(Loss)/Return before Taxation | ( | ( | ( | ( | |||
Taxation | 6 | ||||||
(Loss)/Return for the year | ( | ( | ( | ( | |||
(Loss)/Return per Share (pence) | 7 | ( | ( | ( | ( |
Year ended 31 March 2025 | ||||||
Ordinary | Share | Other | ||||
share | premium | Special | capital | Revenue | ||
capital | account | reserve | reserve | reserve | Total | |
Group | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 |
Opening Shareholders’ funds | ( | |||||
Purchase of own shares into treasury | ( | ( | ||||
Loss for the year | ( | ( | ( | |||
At | ( | |||||
Year ended 31 March 2024 | ||||||
Ordinary | Share | Other | ||||
share | premium | Special | capital | Revenue | ||
capital | account | reserve | reserve | reserve | Total | |
Group | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 |
Opening Shareholders’ funds | ( | |||||
Purchase of own shares into treasury | ( | ( | ||||
Return/(loss) for the year | ( | |||||
At 31 March 2024 | ( |
2025 | 2024 | ||
Note | £’000 | £’000 | |
Non-Current Assets | |||
Investments held at fair value | 8 | ||
Property, plant & equipment | |||
Current Assets | |||
Right-of-use asset | 5 | ||
Other receivables | 10 | ||
Cash and cash equivalents | |||
Total Assets | |||
Current Liabilities | |||
Other payables | 11 | ( | ( |
Lease liability | 5 | ( | ( |
Total Assets less Current Liabilities | |||
Net Assets | |||
Capital and Reserves | |||
Called up share capital | 14 | ||
Share premium | |||
Special reserve | |||
Retained earnings: | |||
Capital reserves | |||
Revenue reserve | ( | ( | |
Total Equity | |||
Net Asset Value per share (pence) | 15 | ||
Net Asset Value per share after performance fee (pence)* | 15 |
Year | Year | |
ended | ended | |
31 March | 31 March | |
2025 | 2024 | |
£’000 | £’000 | |
Operating activities | ||
Sales of investments | ||
Purchases of investments | ( | ( |
Acquisition of property, plant and equipment | ( | ( |
Interest income received | ||
Expenses paid | ( | ( |
Lease payments | ( | ( |
Net cash (outflow)/inflow from operating activities | ( | |
Purchase of own shares into treasury | ( | ( |
Net cash used in financing activities | ( | ( |
Net decrease in cash and cash equivalents | ( | ( |
Cash and cash equivalents at start of year | ||
Cash and cash equivalents at end of year |
2025 | 2024 | |||||
Revenue | Capital | Total | Revenue | Capital | Total | |
£’000 | £’000 | £’000 | £’000 | £’000 | £’000 | |
AIFM fees | 593 | – | 593 | 582 | – | 582 |
Administrative expenses | 1,664 | 165 | 1,829 | 1,706 | 49 | 1,755 |
Directors’ fees* | 192 | – | 192 | 186 | – | 186 |
Performance fee (see note 4)^ | – | – | – | – | – | – |
Staff costs (see note 4) | 2,923 | – | 2,923 | 2,793 | – | 2,793 |
Auditor’s remuneration | 181 | – | 181 | 165 | – | 165 |
Total expenses | 5,553 | 165 | 5,718 | 5,432 | 49 | 5,481 |
2025 | 2024 | |||
Group | Company | Group | Company | |
£’000 | £’000 | £’000 | £’000 | |
Audit of Group accounts pursuant to legislation | 117 | 117 | 110 | 110 |
Audit of subsidiaries accounts pursuant to legislation | 25 | – | 19 | – |
Audit related assurance services | 28 | 28 | 26 | 26 |
Non-audit related assurance services | 11 | – | 10 | – |
Total auditors’ remuneration | 181 | 145 | 165 | 136 |
2025 | 2024 | |||||
Other | Other | |||||
Salary/Fees | benefits | Total | Salary/Fees | benefits | Total | |
£’000 | £’000 | £’000 | £’000 | £’000 | £’000 | |
Directors of the Company's Subsidiary | 1,111 | 102 | 1,213 | 1,158 | 125 | 1,283 |
Non-executive Directors | 192 | – | 192 | 186 | – | 186 |
1,303 | 102 | 1,405 | 1,344 | 125 | 1,469 |
2025 | 2024 | |
£’000 | £’000 | |
Wages and salaries | 2,401 | 2,264 |
Social security costs | 328 | 318 |
Other pension costs | 116 | 119 |
Other staff benefits | 78 | 92 |
Staff costs | 2,923 | 2,793 |
Performance fee (charged to capital)* | – | – |
Total | 2,923 | 2,793 |
2025 | 2024 | |
Group | Group | |
Office Premises | Office Premises | |
£’000 | £’000 | |
As at 1 April | 438 | 588 |
Depreciation | (150) | (150) |
At 31 March | 288 | 438 |
2025 | 2024 | |
Group | Group | |
Office Premises | Office Premises | |
£’000 | £’000 | |
As at 1 April | 474 | 678 |
Rent free period amendment | 19 | (21) |
Interest Expense | 25 | 38 |
Lease Payments | (181) | (221) |
At 31 March | 337 | 474 |
Group | Between | Between | ||
At 31 March 2025 | Up to 3 months | 3 – 12 months | 1 – 2 years | 2 – 5 years |
£’000 | £’000 | £’000 | £’000 | |
Lease payments | – | 181 | 181 | – |
2025 | 2024 | |||||
Revenue | Capital | Total | Revenue | Capital | Total | |
For the year ended 31 March | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 |
Current tax: | ||||||
UK corporate tax on (Loss)/Return for the year | – | – | – | – | – | – |
2025 | 2024 | |||||
Revenue | Capital | Total | Revenue | Capital | Total | |
For the year ended 31 March | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 |
(Loss)/return before taxation | (3,978) | (11,247) | (15,225) | (3,751) | 17,553 | 13,802 |
(Loss)/return before tax multiplied by the effective rate of UK corporation tax of 25% (2024: 25%) | (995) | (2,811) | (3,806) | (938) | 4,388 | 3,450 |
Effects of: | ||||||
Non-taxable capital returns | – | 2,770 | 2,770 | – | (4,400) | (4,400) |
Unutilised management expenses | 995 | 41 | 1,036 | 938 | 12 | 950 |
Total tax expense | – | – | – | – | – | – |
2025 | 2024 | |
£’000 | £’000 | |
Net revenue loss | (3,978) | (3,751) |
Net capital (loss)/return | (11,247) | 17,553 |
Net total (loss)/return | (15,225) | 13,802 |
Weighted average number of ordinary shares in issue | 168,371,133 | 170,877,294 |
Pence | Pence | |
Revenue loss per share | (2.4) | (2.2) |
Capital (loss)/return per share | (6.7) | 10.3 |
Total (loss)/return per share | (9.1) | 8.1 |
2025 | 2024 | |
Group and | Group and | |
Company | Company | |
As at 31 March | £’000 | £’000 |
Unlisted at fair value | 255,997 | 265,083 |
2025 | 2024 | |
Group and | Group and | |
Company | Company | |
£’000 | £’000 | |
As at 1 April | 265,083 | 254,295 |
Purchases at cost | 18,878 | 15,976 |
Realisation proceeds | (16,882) | (22,790) |
(Losses)/gains on investments | (11,082) | 17,602 |
As at 31 March | 255,997 | 265,083 |
2025 | 2025 | 2024 | 2024 | |
Group | Company | Group | Company | |
As at 31 March | £’000 | £’000 | £’000 | £’000 |
Other receivables | 218 | 263 | 245 | 196 |
2025 | 2025 | 2024 | 2024 | |
Group | Company | Group | Company | |
As at 31 March | £’000 | £’000 | £’000 | £’000 |
Other payables | 229 | 206 | 699 | 369 |
Amounts due to investments | 2,932 | 2,932 | – | – |
2025 | 2024 | |
Company | Company | |
As at 31 March | £’000 | £’000 |
Performance fee provision* | 15,244 | 18,980 |
Group | Company | Group | Company | |
Fair value | Fair value | Fair value | Fair value | |
2025 | 2025 | 2024 | 2024 | |
As at 31 March | £’000 | £’000 | £’000 | £’000 |
Financial Assets | ||||
Unlisted equity shares | 245,563 | 245,563 | 259,015 | 259,015 |
Unlisted convertible loan notes | 8,756 | 8,756 | 6,068 | 6,068 |
Deferred consideration | 948 | 948 | – | – |
Cash at bank | 1,559 | 329 | 2,460 | 1,052 |
Cash Equivalents – Liquidity Funds | 30,697 | 29,600 | 36,045 | 35,000 |
Other assets | 506 | 263 | 683 | 196 |
Financial Liabilities | ||||
Other payables and lease liabilities | (3,498) | (3,138) | (1,173) | (369) |
As at 31 March 2025 | Weighted | ||||||
Fair value of | Key | Other | Applied | average | Sensitivity | Change in | |
investments | unobservable | Unobservable | Multiple | multiple | +/- | Valuation | |
Valuation approach | £’000 | inputs | inputs | Range | applied# | % | +/- £’000 |
Market approach using | Revenue Multiple‡ | a, b, c, g | 0.8x - 18.4x | 6.2x | 10% | 21,398/(21,812) | |
comparable traded multiples | Earnings Multiple | a, b, c, g | 5.6x - 15.8x | 9.8x | 10% | 3,659/(3,659) | |
AUM Multiple | a, b, c, g | – | – | – | – | ||
222,019 | Illiquidity discount | d,g | 7% - 80% | 21.1% | 30% | 26,080/(22,988) | |
Transaction implied | e, g | 20% - 180% | 62.4% | 30% | 7,209/(8,393) | ||
premiums and | |||||||
discounts | |||||||
Net Asset Value** | 6,509 | Discount to NAV | a | n/a | n/a | 10% | (650) |
PWERM* | 8,756 | Probability of | a | n/a | n/a | 25% | 319/(399) |
conversion | |||||||
Expected transaction price | – | Execution | a, f | n/a | n/a | n/a | n/a |
risk discount | |||||||
CPORT^ | 16,351 | Transaction Price | a,e,g | n/a | n/a | 10% | 1,710/(1,710) |
Sales Price | 2,361 | n/a | n/a | n/a | n/a | n/a | n/a |
As at 31 March 2024 | Weighted | ||||||
Fair value of | Key | Other | Applied | average | Sensitivity | Change in | |
investments | unobservable | Unobservable | Multiple | multiple | +/- | Valuation | |
Valuation approach | £’000 | inputs | inputs | Range | applied# | % | +/- £’000 |
Market approach using | Revenue Multiple ‡ | a, b, c, g | 2.3x – 28.0x | 6.0x | 10% | 17,564/(17,554) | |
comparable traded multiples | Earnings Multiple | a, b, c, g | 6.3x-18.6x | 11.0x | 10% | 3,146/(2,423) | |
AUM Multiple | a, b, c, g | 0.1x | 0.1x | 10% | 264/- | ||
217,054 | Illiquidity discount | d,g | 0% - 50% | 32.3% | 30% | 12,558/(10,920) | |
Transaction implied | e, g | 0% - 630% | 109.3% | 30% | 17,063/(18,023) | ||
premiums and | |||||||
discounts | |||||||
Net Asset Value** | 8,264 | Discount to NAV | a | n/a | n/a | 10% | (826) |
PWERM* | 6,068 | Probability of | a | n/a | n/a | 25% | 248/(248) |
conversion | |||||||
Expected transaction price | 7,135 | Execution | a, f | n/a | n/a | 10% | 713/(713) |
risk discount | |||||||
CPORT^ | 16,414 | Transaction Price | a,e,g | n/a | n/a | 10% | 1,641/(1,641) |
Sales Price | 10,148 | n/a | n/a | n/a | n/a | n/a | n/a |
2025 | 2024 | |||
Ordinary Shares | Ordinary Shares | |||
No. | £’000 | No. | £’000 | |
Opening issued and fully paid ordinary shares of 1p each | 169,831,285 | 1,810 | 174,518,852 | 1,810 |
Ordinary shares purchased into treasury | (2,550,383) | – | (4,687,567) | – |
Closing issued and fully paid ordinary shares of 1p each | 167,280,902 | 1,810 | 169,831,285 | 1,810 |
Group | Group | |
2025 | 2024 | |
£’000 | £’000 | |
Equity | ||
Equity share capital | 1,810 | 1,810 |
Retained earnings and other reserves | 283,606 | 301,507 |
Total capital and reserves | 285,416 | 303,317 |